These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12727074)

  • 1. Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains.
    Limoncu MH; Ermertcan S; Cetin CB; Cosar G; Dinç G
    Int J Antimicrob Agents; 2003 May; 21(5):420-4. PubMed ID: 12727074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
    Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
    Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
    Kang SL; Rybak MJ; McGrath BJ; Kaatz GW; Seo SM
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2702-9. PubMed ID: 7695250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin.
    Evans ME; Titlow WB
    J Antimicrob Chemother; 1998 Feb; 41(2):285-8. PubMed ID: 9533474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1662-7. PubMed ID: 9257737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates.
    Muller-Serieys C; Decré D; Benoit C; Bigot C; Maubert B; Carbon C
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():67-70. PubMed ID: 10404341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
    Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
    Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
    Licata L; Smith CE; Goldschmidt RM; Barrett JF; Frosco M
    Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
    Zhang YH; Liu XY; Zhu LL; Yu YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
    Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.
    Blumberg HM; Rimland D; Carroll DJ; Terry P; Wachsmuth IK
    J Infect Dis; 1991 Jun; 163(6):1279-85. PubMed ID: 2037793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of methicillin-sensitive and methicillin-resistant staphylococci to ciprofloxacin].
    Namysł E; Piechowicz L; Krzywińska E; Galiński J
    Med Dosw Mikrobiol; 1993; 45(2):149-52. PubMed ID: 8309287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
    Noviello S; Ianniello F; Leone S; Esposito S
    Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
    Hesje CK; Borsos SD; Blondeau JM
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates.
    Blumberg HM; Rimland D; Kiehlbauch JA; Terry PM; Wachsmuth IK
    J Clin Microbiol; 1992 Feb; 30(2):362-9. PubMed ID: 1371517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.